Morgan Stanley’s Cadrenal Therapeutics CVKD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.18K	Sell	430 -700	-62%	-$8.44K	﹤0.01%	7024
2025 Q1	$19.9K	Sell	1,130 -16	-1%	-$282	﹤0.01%	6572
2024 Q4	$16.6K	Buy	+1,146	New	+$16.6K	﹤0.01%	6628